跳到主要內容區

資訊分類清單

  1. 首頁
  2. 分醫團隊
  3. 師資陣容

劉紋君 publication

 

Wen-Chun,Liu

 

研究成果 ( Publications) 

A.期刊論文 Refereed Papers

  1. Liu J, Lv X, Ye T, Zhao M, Chen Z, Zhang Y, Yang W, Xie H, Zhan L, Chen L, Liu WC, Su KP, Sun J. Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach. Brain Behav Immun. 2024 Jan 9;117:270-282.
  2. Iqbal AZ, Wu SK, Zailani H, Chiu WC, Liu WC, Su KP, Lee SD. Effects of Omega-3 Polyunsaturated Fatty Acids Intake on Vasomotor Symptoms, Sleep Quality and Depression in Postmenopausal Women: A Systematic Review. Nutrients. 2023 Sep 30;15(19):4231.
  3. Chou PH, Liu WC, Wang SC, Lin WH, Chung YL, Chang CH, Su KP. Associations between frontal lobe activity and depressive symptoms in patients with major depressive disorder receiving rTMS treatment: a near-infrared spectroscopy study. Front Psychiatry. 2023 Aug 16;14:1235713
  4. Chou PH, Liu WC, Lin WH, Hsu CW, Wang SC, Su KP. NIRS-aided differential diagnosis among patients with major depressive disorder, bipolar disorder, and schizophrenia. J Affect Disord. 2023 Nov 15;341:366-373.
  5. Wu JS, Hong TC, Wu HT, Lin YJ, Chang TT, Wang CT, Liu WC, Hsieh MT, Wu IC, Chen PJ, Chen CY, Lin SH, Chuang CH, Han MZ, Chen HP, Tsai HM, Kuo HY. Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan. J Gastrointest Oncol. 2023 Apr 29;14(2):849-862.
  6. Tseng CW, Liu WC, Ko PH, Chen YC, Tseng KC, Chang TT. The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients. Viruses. 2022 Aug 18;14(8):1812.
  7. Tseng CW, Liu WC, Chen CY, Chang TT, Tseng KC. Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV. BMC Infect Dis. 2022 Apr 9;22(1):351.
  8. Wu IC, Liu WC*, Chiu YC, Chiu HC, Cheng PN, Chang TT. Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss. Microorganisms. 2021 May 26;9(6):1146. (Co-first author)
  9. Liu WC, Wu IC, Chiu YC, Tseng KC, Chen CY, Chiu HC, Cheng PN, Chang TT. Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients. Antiviral Res. 2020 Jan 28:104719. (First author)
  10. Lin TC, Liu WC, Hsu YH, Lin JJ, Chiu YC, Chiu HC, Cheng PN, Chen CY, Chang TT, Wu IC. Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy. J Clin Med. 2019 Nov 6;8(11). pii: E1892.
  11. JH Cheng, Liu WC, TT Chang, SY Hsieh and VS Tseng, "An Effective and Efficient Algorithm for Detecting Exact Deletion Breakpoints from Viral Next-Generation Sequencing Data," 2020 International Computer Symposium (ICS), Tainan, Taiwan, 2020, pp. 147-152.
  12. Wu IC, Liu WC*, Chang TT. Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations. J Biomed Sci. 2018 Jun 2;25(1):51. (Co-first author)
  13. Lin TC, Chiu YC, Chiu HC, Liu WC, Cheng PN, Chen CY, Chang TT, Wu IC. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy. World J Gastroenterol. 2018 Feb 14;24(6):725-736.
  14. Cheng JH, Liu WC, Chang TT, Hsieh SY, Tseng VS. Detecting exact breakpoints of deletions with diversity in hepatitis B viral genomic DNA from next-generation sequencing data. Methods. 2017 Oct 1;129:24-32. 28802713.
  15. Liu WC, Wu IC, Lee YC, Lin CP, Cheng JH, Lin YJ, Yen CJ, Cheng PN, Li PF, Cheng YT, Cheng PW, Sun KT, Yan SL, Lin JJ, Yang JC, Chang KC, Ho CH, Tseng VS, Chang BC, Wu JC, Chang TT. Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus. J Pathol. 2017 Oct;243(2):176-192. (First author)
  16. Ho CH, Tsai HW, Lee CY, Huang LJ, Chien RN, Wu IC, Chiu YC, Liu WC, Cheng PN,  Chang TT, Chen SH. Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG. Sci Rep. 2017 May 16;7(1):1957.
  17. Cheng CP, Lan KL, Liu WC, Chang TT, Tseng VS. DeF-GPU: Efficient and effective deletions finding in hepatitis B viral genomic DNA using a GPU architecture. Methods. 2016 Dec 1;111:56-63.
  18. Ho CH, Chuang HC, Wu IC, Tsai HW, Lin YJ, Sun HY, Young KC, Chiu YC, Cheng PN, Liu WC, Tan TH, Chang TT. Prediction of early hepatocellular carcinoma recurrence using germinal center kinase-like kinase. Oncotarget. 2016 Aug 2;7(31):49765-49776.
  19. Liu WC, Lin CP, Cheng CP, Ho CH, Lan KL, Cheng JH, Yen CJ, Cheng PN, Wu IC, Li IC, Chang BC, Tseng VS, Chiu YC, Chang TT. Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus. Hepatol Int. 2016 Jan;10(1):147-57. (First author)
  20. Ho CH, Chien RN, Cheng PN, Liu CK, Su CS, Wu IC, Liu WC, Chen SH, Chang TT. Association of serum IgG N-glycome and transforming growth factor-β1 with hepatitis B virus e antigen seroconversion during entecavir therapy. Antiviral Res. 2014 Nov;111:121-8.
  21. Ho CH, Chien RN, Cheng PN, Liu JH, Liu CK, Su CS, Wu IC, Li IC, Tsai HW, Wu SL, Liu WC, Chen SH, Chang TT. Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy. J Infect Dis. 2015 Jan 1;211(1):115-24.
  22. Tseng KC, Chen CY, Tsai HW, Chang TT, Chuang WL, Hsu PI, Liu WC, Cheng PN. Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study. Antivir Ther. 2014;19(8):755-64.
  23. Cheng CP, Lee PF, Liu WC, Wu IC, Chin CY, Chang TT, Tseng VS. Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive chronic hepatitis B patients. PLoS One. 2012;7(2):e32553.
  24. Sun HY, Ou NY, Wang SW, Liu WC, Cheng TF, Shr SJ, Sun KT, Chang TT, Young KC. Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses. PLoS One. 2011;6(9):e25530.
  25. Cheng PN, Liu WC, Tsai HW, Wu IC, Chang TT, Young KC. Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic  hepatitis B patients receiving oral antiviral agents. J Med Virol. 2011 Apr;83(4):602-7.
  26. CP Cheng, PF Lee, CY Chin, Liu WC et al., "Discovering Clinical Biomarkers of Chronic Hepatitis B by Mining Mutation Hotspots," 2011 International Conference on Technologies and Applications of Artificial Intelligence, Chung Li, Taiwan, 2011, pp. 51-56.
  27. KT Sun, CH Wei, YY Hsu, Liu WC, TT Chang. On Deriving an Equation of the Mutation Rate of the Hepatitis B Virus. J. Convergence Inf. Technol.2010; 5(5):131-7
  28. Tseng KC, Cheng PN, Wu IC, Chang CK, Chou AL, Liu WC, Chang TT. HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during adefovir dipivoxil therapy. Hepatogastroenterology. 2009 May-Jun;56(91-92):813-8.
  29. Liu WC, Lindh M, Buti M, Phiet PH, Mizokami M, Li HH, Sun KT, Young KC, Cheng PN, Wu IC, Chang TT. Genotyping of hepatitis B virus--genotypes a to g by multiplex polymerase chain reaction. Intervirology. 2008;51(4):247-52. (First author)
  30. Liu WC, Phiet PH, Chiang TY, Sun KT, Hung KH, Young KC, Wu IC, Cheng PN, Chang TT. Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics. Virus Res. 2007 Nov;129(2):212-23. (First author)
  31. Wu IC, Chow NH, Cheng PN, Liu WC, Young KC, Chang WL, Chen CY, Tseng KC, Chang TT. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B. J Med Virol. 2007 Jun;79(6):663-9.
  32. Liu WC, Mizokami M, Buti M, Lindh M, Young KC, Sun KT, Chi YC, Li HH, Chang TT. Simultaneous quantification and genotyping of hepatitis B virus for genotypes A to G by real-time PCR and two-step melting curve analysis. J Clin Microbiol. 2006 Dec;44(12):4491-7. (First author)
  33. Young KC, Lindsay KL, Lee KJ, Liu WC, He JW, Milstein SL, Lai MM. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology. 2003 Oct;38(4):869-78.

B. 研討會論文 Conference papers

  1. Wen-Chun Liu, Ting-Tsung Chang. Single Nucleotide Variants Associated with Viral Replication Efficiency Identified Using Genome-Wide Next-Generation Sequencing Analysis of Hepatitis B Virus. The 5th International Symposium on Infectious Disease and Signal Transduction /2015 Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation. Nov. 14th -15th, 2015
  2. Ting-Tsung Chang, Wen-Chun Liu. Characteristics of HBV Quasispecies Associated with Hepatocellular Carcinoma by Next-Generation Sequencing and Database Meta-Analysis The 4th International Symposium on Infectious Disease and Signal Transduction/ 2014 Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation. Nov. 1st -2nd, 2014.
  3. Wen-Chun Liu, I-Chin Wu, Ting-Tsung Chang. Mapping of PreS-Deletion Within the Hepatitis B Virus Genome Among Chronic Hepatitis B Patients With Hepatocellular Carcinoma by Next-Generation Sequencing. The 4th International Symposium on Infectious Disease and Signal Transduction/ 2014 Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation. Nov. 1st -2nd, 2014.
  4. Wen-Chun Liu, Chia-Han Chan, Vincent Shin-Mu Tseng, Chia-Jui Yen, Pin-Nan Cheng, I-Chin Wu, Yen-Cheng Chiu, Yu-Ping Lin, Cheng-Hsun Ho, Ting-Tsung Chang. Comparison of serum hepatitis B virus quasispecies in HBV-related hepatocellular carcinoma and chronic hepatitis B patients by Next-generation sequencing (NGS). The 22nd Conference of the Asian Pacific Association for the Study of the Liver. February 16-19 2012

 

a. 國際會議 International Conference

  1. Wen-Chun Liu, Ting-Tsung Chang. Single Nucleotide Variants Associated with Viral Replication Efficiency Identified Using Genome-Wide Next-Generation Sequencing Analysis of Hepatitis B Virus. The 5th International Symposium on Infectious Disease and Signal Transduction /2015 Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation. Nov. 14th -15th, 2015
  2. Ting-Tsung Chang, Wen-Chun Liu. Characteristics of HBV Quasispecies Associated with Hepatocellular Carcinoma by Next-Generation Sequencing and Database Meta-Analysis The 4th International Symposium on Infectious Disease and Signal Transduction/ 2014 Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation. Nov. 1st -2nd, 2014.
  3. Wen-Chun Liu, I-Chin Wu, Ting-Tsung Chang. Mapping of PreS-Deletion Within the Hepatitis B Virus Genome Among Chronic Hepatitis B Patients With Hepatocellular Carcinoma by Next-Generation Sequencing. The 4th International Symposium on Infectious Disease and Signal Transduction/ 2014 Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation. Nov. 1st -2nd, 2014.
  4. Wen-Chun Liu, Chia-Han Chan, Vincent Shin-Mu Tseng, Chia-Jui Yen, Pin-Nan Cheng, I-Chin Wu, Yen-Cheng Chiu, Yu-Ping Lin, Cheng-Hsun Ho, Ting-Tsung Chang. Comparison of serum hepatitis B virus quasispecies in HBV-related hepatocellular carcinoma and chronic hepatitis B patients by Next-generation sequencing (NGS). The 22nd Conference of the Asian Pacific Association for the Study of the Liver. February 16-19 2012

 

 

 

 

瀏覽數:
加到我的最愛
友善列印